BCCA Protocol Summary for Adjuvant Therapy for Breast ...

Oncology Nutrition High Protein High Energy …

High Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)

  High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods

BC CANCER HAZARDOUS DRUG LIST

BC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:

  Lists, Hazardous

Safe Handling of Hazardous Drugs - BC Cancer

A.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....

  Drug, Lists, Hazardous, Hazardous drugs

“Magic” mouthwash explained - BC Cancer

FAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,

  Magic, Explained, Mouthwash, Magic mouthwash explained

Symptom Management Guidelines: ORAL …

Symptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …

  Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis

Guidelines for Management of CID - BC Cancer

Disclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide

  Guidelines, Management, Guidelines for management of cid

British Columbia Cancer Agency POLICY

British Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997

  Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy

Symptom Management Guidelines: FEVER AND …

Symptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h

  Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia

Symptom Management Guidelines: XEROSTOMIA

Symptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be

  Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia

Linking the BC Psychosocial Community Oncology …

Carolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC

  Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology

AC (DOXOrubicin/Cyclophosphamide) Every 21 Days Course

CHEMOTHERAPY REGIMEN. 21-day cycle for 4 cycles • DOXOrubicin 60 mg/m2 IV Push on Day 1 • Cyclophosphamide 600 mg/m2 IV over 30 minutes on Day 1 • Oral hydration is strongly encouraged with cyclophosphamide; poorly hydrated patients may need supplemental IV hydration.

  Every, Doxorubicin, Days, Cyclophosphamide, Doxorubicin cyclophosphamide, Every 21 days

BCCA Protocol Summary for Adjuvant Therapy for Breast ...

(use non-DEHP bag and non-DEHP tubing with 0.22 micron or smaller in-line filter) Repeat cycle every 21 days x 4 cycles . DOSE MODIFICATIONS: 1. Hematological (for Day 1 counts)

  Every, Days, Every 21 days

BREAST CANCER TREATMENT REGIMENS (Part 1 of 6)

BREAST CANCER TREATMENT REGIMENS (Part 3 of 6) REGIMEN DOSING Recurrent or Metastatic Breast Cancer—Combination Therapy (continued) AT (doxorubicin + paclitaxel)1,20 Day 1: Doxorubicin 60mg/m 2 IV + paclitaxel 125–200mg/m 2 IV. Repeat cycle every 3 weeks.

  Treatment, Part, Every, Breast, Cancer, Doxorubicin, Regimens, Breast cancer treatment regimens

Protocol: AC (Doxorubicin/Cyclophosphamide)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 19 Protocol: Paclitaxel Indications: Breast Cancer – Adjuvant (high risk), Palliative

  Protocol, Doxorubicin, Cyclophosphamide, Doxorubicin cyclophosphamide

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

One vial contains 150 mg of trastuzumab, a humanised IgG1 monoclonal antibody produced by mammalian (Chinese hamster ovary) cell suspension culture and purified by affinity and ion exchange